Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Journal of the American College of Cardiology

• Publication date

  1986-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0735-1097(86)80296-0PMID 2946740
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of intimal dissection on restenosis after successful coronary angioplasty.

  1985cited by this paper
• Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty.

  1985cited by this paper
• [Results of coronary transluminal angioplasty following Prinzmetal's angina or fixed stenosis with associated spasm].

  1984cited by this paper
• Repeat coronary angioplasty.

  1984cited by this paper
• Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.

  1984cited by this paper
• Role of platelet antagonists in coronary artery disease: implications in coronary artery bypass surgery and balloon-catheter dilatation.

  1984cited by this paper
• A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes.

  1984cited by this paper
• Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute.

  1984cited by this paper
• Coronary artery spasm at the site of angioplasty in the first 2 months after successful percutaneous transluminal coronary angioplasty.

  1983cited by this paper
• Long-term responses to nifedipine in patients with coronary spasm who have an initial favorable response.

  1983cited by this paper
• Treatment of vasospastic angina.

  1983cited by this paper
• Clinical observations on coronary spasm and percutaneous coronary artery angioplasty

  1982cited by this paper
• Percutaneous Transluminal Coronary Angioplasty in Patients with Variant Angina

  1982cited by this paper
• Nifedipine therapy for coronary-artery spasm. Experience in 127 patients.

  1980cited by this paper
• Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty.

  1979cited by this paper
• Transluminal dilatation of coronary-artery stenosis.

  1978cited by this paper

• Updates on Intrinsic Medicinal Chemistry of 1,4-dihydropyridines, Perspectives on Synthesis and Pharmacokinetics of Novel 1,4-dihydropyrimidines as Calcium Channel Blockers: Clinical Pharmacology.

  2025cites this paper
• The quest for effective pharmacological suppression of neointimal hyperplasia.

  2020cites this paper
• Predictors of angiographic restenosis in patients with coronary artery disease who have undergone percutaneous coronary intervention with drug eluting stents

  2018cites this paper
• Risk Factors, Interventions and Therapeutic Agents in the Prevention of Atherosclerosis-Related Ischaemic Diseases

  2012cites this paper
• A Review of its Pharmacodynamic and Pharmacokinetic Properties , and Therapeutic Potential in Cardiovascular Disease

  2012cites this paper
• Pharmacological Approaches to the Prevention of Restenosis Following Angioplasty

  2012cites this paper
• Pharmacological Approaches to the Prevention of Restenosis Following Angioplasty

  2012cites this paper
• Role of Calcium Channel Blockers in Reducing Acute Ischaemia and Preventing Restenosis in PTCA

  2012cites this paper
• Effect of a dihydropyridine-type calcium channel blocker on vascular remodeling after experimental balloon angioplasty.

  2011cites this paper
• Percutaneous Treatment of Coronary Artery Disease

  2010cites this paper
• Calcium channel regulation in vascular smooth muscle cells: synergistic effects of statins and calcium channel blockers.

  2010cites this paper
• to control restenosis after angioplasty

  2010cites this paper
• [Restenosis after PTCA].

  2008cites this paper
• Hochfrequenz-Rotationsatherektomie bei koronarer Herzkrankheit

  2008cites this paper
• Animals Models in Restenosis The Pig Restenosis Model

  2008cites this paper
• Percutaneous coronary angioplasty: Technique, indications, and results

  2007cites this paper
• Simultane intra- und extravaskuläre Applikation von Hochdosisdiltiazem in einem koronaren Schweine-Organkulturmodell

  2006influential citation
• XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China.

  2006cites this paper
• Koronare Stents / Von der Idee zum High–Tech–Implantat

  2005cites this paper
• Percutaneous transluminal coronary angioplasty: state of the art and future directions

  2005cites this paper
• Preclinical Investigation of Agents Used in Current Restenosis Trials Preclinical Animal Mechanism of Animal and in vitro data model injury findings Platelet receptor and mediator inhibitors GR 32191 Yes Rat Balloon injury Platelet inhibition I Intimal hyperplasia * Sulotroban No

  2005cites this paper
• Defining Coronary Restenosis

  2005cites this paper
• A Practical Proliferative Model in Porcine Coronary Arteries

  2005cites this paper
• Einfluss von Kalzifizierungen der menschlichen Koronararterie auf die Strahlendosis im Bereich der Adventitia Dosimetrischer Vergleich von β- und γ-Strahlern mit Hilfe der Thermolumineszens-Dosimetrie

  2005cites this paper
• Clinical and Angiographic Characteristics of 10 Patients with Prinzmetal ' s Variant Angina Pectoris Cholesterol Coronary arteriography Age CAD ( mg / dl ) ST at initial evaluation Follow-up Patient ( years ) Sex risk factors Entry Outset

  2005cites this paper
• [Coronary stents. From a simple idea to a medical high-tech device].

  2005cites this paper
• Perivascular delivery of neomycin inhibits the activation of NF-κB and MAPK pathways, and prevents neointimal hyperplasia and stenosis after arterial injury

  2004cites this paper
• Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: the randomized, double-blind, placebo-controlled, multicenter Verapamil Slow-Release for Prevention of Cardiovascular Events After Angioplasty (VESPA) Trial.

  2004cites this paper
• Inhibition of postangioplasty restenosis using antisense approach

  2003cites this paper
• recurrent stenosis . angioplasty in patients at high risk of Verapamil treatment after coronary

  2003cites this paper
• Development of New Coronary Stent-Grafts using Surface-Modified Polymers

  2003cites this paper
• Therapeutic potential of active stent coating

  2003cites this paper
• Perivascular Endothelial Cell Tissue Engineering

  2003cites this paper
• Effect of Endothelial Shear Stress on the Progression of Coronary Artery Disease, Vascular Remodeling, and In-Stent Restenosis in Humans: In Vivo 6-Month Follow-Up Study

  2003cites this paper
• Perspectives of Drug-Eluting Stents

  2002cites this paper
• Preventing cardiac events and restenosis after percutaneous coronary intervention.

  2002cites this paper
• Inorganic materials as drug delivery systems in coronary artery stenting

  2002cites this paper
• Can Angiotensin Receptor Antagonists Prevent Restenosis After Stent Placement?

  2002cites this paper
• Mesenchymal Cell Culture

  2002cites this paper
• Stent Coating: A New Approach in Interventional Cardiology

  2002cites this paper
• Intracoronary radiation therapy.

  2001cites this paper
• Fibrin sealant coated stents compared with non-coated stents in a porcine carotid artery model. Preliminary study report.

  2001cites this paper
• Overview of therapies for prevention of restenosis after coronary interventions.

  2001cites this paper
• An Iron-Binding Exochelin Prevents Restenosis Due to Coronary Artery Balloon Injury in a Porcine Model

  2001cites this paper
• Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy.

  2001cites this paper
• An updated meta-analysis of calcium-channel blockers in the prevention of restenosis after coronary angioplasty.

  2001cites this paper
• Endovascular radiotherapy for stenosis after percutaneous transluminal coronary angioplasty.

  2001cites this paper
• Usefulness of Nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study). NIsoldipine in COronary artery disease in LEuven.

  2001cites this paper
• Effects of probucol on rat carotid artery responses to balloon catheter injury.

  2001cites this paper
• The Restenosis Story: Is Intracoronary Radiation Therapy the Solution?

  2001cites this paper
• Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES).

  2000cites this paper
• Results and clinical implications of the CAPARES trial.

  2000cites this paper
• Strategien zur Verhinderung der Rezidivstenose nach Katheterintervention

  2000cites this paper
• Expression of allograft inflammatory factor-1 is a marker of activated human vascular smooth muscle cells and arterial injury.

  2000cites this paper
• der Rezidivstenose nach Katheterintervention

  2000cites this paper
• Influence of calcium antagonists on long-term survival of patients treated with coronary angioplasty.

  1999cites this paper
• The Utility of Animal Models in the Preclinical Study of Interventions to Prevent Human Coronary Artery Restenosis: Analysis and Recommendations

  1999cites this paper
• Pharmacologic effects of calcium channel blockers on restenosis.

  1999cites this paper
• Endoluminal Radiation Therapy

  1999cites this paper
• Time course and importance of neoadventitial formation in arterial remodeling following balloon angioplasty of porcine coronary arteries.

  1999cites this paper
• Current status of calcium channel blockers in patients with cardiovascular disease.

  1999cites this paper
• Impact of routine angiographic follow-up after angioplasty.

  1998cites this paper
• [Mechanisms and prevention of restenosis after coronary angioplasty].

  1998cites this paper
• Remodeling after directional coronary atherectomy (with and without adjunct percutaneous transluminal coronary angioplasty): a serial angiographic and intravascular ultrasound analysis from the Optimal Atherectomy Restenosis Study.

  1998cites this paper
• Characterization of a positron emitting V48 nitinol stent for intracoronary brachytherapy.

  1998cites this paper
• [Prevention and treatment of restenosis after percutaneous transluminal coronary angioplasty].

  1998cites this paper
• Pharmacological Approaches to the Prevention of Restenosis After Coronary Angioplasty

  1998cites this paper
• Prävention und Behandlung der Restenose nach perkutaner transluminaler Koronarangioplastie

  1998cites this paper
• Therapy and clinical trials.

  1998cites this paper
• Medical therapies for the prevention of restenosis after percutaneous coronary interventions.

  1998cites this paper
• Restenosis, the Achilles' Heel of Coronary Angioplasty

  1998cites this paper
• Critical analysis of coronary artery bypass graft surgery: a 30-year journey.

  1998cites this paper
• The development of interventional cardiology.

  1998cites this paper
• Effect of high dose verapamil on restenosis after peripheral angioplasty.

  1998cites this paper
• Autologous vein lined and vein covered stents in swine arteries. An experimental study to assess and compare patency and intimal hyperplastic response.

  1998cites this paper
• Kathetergestützte Verfahren zur Verringerung der Restenoserate nach Koronarangioplastie: Ein Überblick zur Strahlentherapie

  1998cites this paper
• Therapy and clinical trials.

  1998cites this paper
• Short‐term exposure to low concentrations of thapsigargin inhibits replication of cultured human vascular smooth muscle cells

  1997cites this paper
• Effect of cilostazol in preventing restenosis after percutaneous transluminal coronary angioplasty.

  1997cites this paper
• Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures.

  1997cites this paper
• Intravascular Ultrasound Assessment of the Mechanisms and Predictors of Restenosis Following Coronary Angioplasty.

  1997cites this paper
• Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention.

  1997cites this paper
• Editors' announcement

  1997cites this paper
• Clinical Trials to Prevent Restenosis after Percutaneous Coronary Revascularization

  1997cites this paper
• Pharmacologic Perspectives of Remodeling Inhibition

  1997cites this paper
• Impact of medication nonadherence on coronary heart disease outcomes. A critical review.

  1997cites this paper
• Clinical promise of calcium antagonists in the angioplasty patient.

  1997cites this paper
• [Nifedipine and coronary insufficiency: reasons for controversy].

  1997cites this paper
• Recurrent carotid stenosis after carotid endarterectomy

  1997cites this paper
• High-dose diltiazem prevents migration and proliferation of vascular smooth muscle cells in various in-vitro models of human coronary restenosis.

  1997cites this paper
• Short-term exposure to thapsigargin inhibits neointima formation in human saphenous vein.

  1997cites this paper
• Restenosis: is there a pharmacologic fix in the pipeline?

  1997cites this paper
• Quantitative Angiographic Analysis of PTCA-Induced Coronary Vasoconstriction in Single-Vessel Coronary Artery Disease

  1997cites this paper
• Restenosis after coronary angioplasty.

  1997cites this paper
• Local drug delivery: current applications.

  1997cites this paper
• Mechanisms of Neointima Formation—Lessons from Experimental Models

  1997cites this paper
• Effects of pemirolast and tranilast on intimal thickening after arterial injury in the rat.

  1997cites this paper
• Experimental models of accelerated atherosclerosis syndromes.

  1996cites this paper
• Mechanisms and prevention of restenosis: from experimental models to clinical practice.

  1996cites this paper
• Role of intimal hyperplasia and arterial remodeling after balloon angioplasty: an experimental study in the atherosclerotic rabbit model.

  1996cites this paper